Session-aware quotes · provider delays vary · Not financial advice
BearishMEDIUM severityTech & AI12d ago

Aquestive targets Q3 NDA resubmission for Anaphylm while maintaining 2026 revenue guidance of $46M-$50M

Reported by Seeking Alpha · seekingalpha.com · August 12, 2026

$AQST
Bearish read

What the tape says

What to watch: Demand softness or margin pressure in tech often leads broader market sentiment.

Amount
$46 million
Amount
$50 million

Market reaction today: $AQST +3.00%

Tone and severity are deterministic keyword classification — not a prediction, a member vote, or a recommendation. Figures are extracted from the headline as published. Wook does not republish Seeking Alpha's reporting.

Your read

Discussion

No one has weighed in yet. Start the discussion on this story.

Headline and link are attributed to Seeking Alpha. Wook of Wall Street is an independent research tool and is not affiliated with Seeking Alpha. Nothing here is financial advice or a recommendation — research and educational content only.